Home
>
National Drug Code (NDC)
>
Inspra
Inspra - 0025-1720-03 - (EPLERENONE)
Drug Information of Inspra
| Product NDC: | 0025-1720 |
| Proprietary Name: | Inspra |
| Non Proprietary Name: | EPLERENONE |
| Active Ingredient(s): | 50 mg/1 & nbsp; EPLERENONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Inspra
| Product NDC: | 0025-1720 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021437 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020927 |
Package Information of Inspra
| Package NDC: | 0025-1720-03 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0025-1720-03) |
NDC Information of Inspra
| NDC Code | 0025-1720-03 |
| Proprietary Name | Inspra |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0025-1720-03) |
| Product NDC | 0025-1720 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | EPLERENONE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020927 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | EPLERENONE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |
